Aurora Diotallevi

11PUBLICATIONS
43CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsImmunogenetics (incl. genetic immunology)Biomolecular modelling and designProteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 11, 2026
Second Generation of 2,2'-Di(indol-3-yl)ethanamines as Antileishmanial Agents: Phenotypic Hit Identification and Pharmacophore Studies.

|Jan 30, 2026
In vitro activity of gallium-protoporphyrin IX against Leishmania major and Leishmania infantum.

Sara Maestrini, Aurora Diotallevi, Sarah Hijazi

|Jun 13, 2024
Exploring hydrophilic 2,2-di(indol-3-yl)ethanamine derivatives against Leishmania infantum.

Alessia Centanni, Aurora Diotallevi, Gloria Buffi

|Feb 23, 2024
Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania In Vitro Infections.

José Vitorino Dos Santos, Jorge Mansur Medina, Karina Luiza Dias Teixeira

|May 27, 2023
Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay.

Chiara Orlandi, Giuseppe Stefanetti, Simone Barocci

|Jun 27, 2022
The host micro-RNA cfa-miR-346 is induced in canine leishmaniasis.

Gloria Buffi, Aurora Diotallevi, Marcello Ceccarelli

Pageof 2

Frequent Collaborators

11 joint publications

Luca Galluzzi

5 joint publications

Mauro Magnani

3 joint publications

Simone Lucarini

2 joint publications

Germano Castelli